Compounds > indazoles
Page last updated: 2024-08-21

indazoles and guanine

indazoles has been researched along with guanine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Adjei, AA; Allen, R; Bendell, JC; Burris, HA; Dy, GK; Huff, A; Infante, JR; Ma, WW; Novello, S; Ottesen, LH; Suttle, AB; Wang, Q; Xu, CF1
Besse, B; Bosquee, L; Chouaid, C; Felip, E; Lechevalier, T; Lianes-Barragán, P; Mellemgaard, A; Ottesen, LH; Paul, EM; Reck, M; Ruiz-Soto, R; Scagliotti, GV; Sigal, E; von Pawel, J1
Belani, CP; Bondarenko, IM; Bycott, P; Ingrosso, A; Kim, S; Niethammer, AG; Novello, S; Poltoratskiy, A; Scagliotti, GV; Tang, J; Yamamoto, N1
Jena, NR; Shah, PK; Shukla, PK1

Trials

3 trial(s) available for indazoles and guanine

ArticleYear
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.
    Investigational new drugs, 2013, Volume: 31, Issue:4

    Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Demography; Dose-Response Relationship, Drug; Female; Glutamates; Guanine; Humans; Indazoles; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms; Pemetrexed; Pyrimidines; Sulfonamides

2013
An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:12

    Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Follow-Up Studies; Glutamates; Guanine; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pemetrexed; Prognosis; Pyrimidines; Sulfonamides; Survival Rate

2013
Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer.
    BMC cancer, 2014, Apr-25, Volume: 14

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Female; Glutamates; Guanine; Humans; Imidazoles; Indazoles; Male; Middle Aged; Pemetrexed; Vascular Endothelial Growth Factor A

2014

Other Studies

2 other study(ies) available for indazoles and guanine

ArticleYear
StatBite: FDA oncology drug product approvals in 2009.
    Journal of the National Cancer Institute, 2010, Feb-24, Volume: 102, Issue:4

    Topics: Administration, Oral; Aminopterin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Cetuximab; Depsipeptides; Drug Approval; Everolimus; Ferrosoferric Oxide; Glutamates; Guanine; Humans; Indazoles; Injections; Panitumumab; Pemetrexed; Pyrimidines; Sirolimus; Sulfonamides; United States; United States Food and Drug Administration

2010
Reactions of Ru(III)-drugs KP1019 and KP418 with guanine, 2'-deoxyguanosine and guanosine: a DFT study.
    Journal of molecular modeling, 2022, Sep-05, Volume: 28, Issue:10

    Topics: Antineoplastic Agents; Deoxyguanosine; DNA; Guanine; Guanosine; Indazoles; Organometallic Compounds; RNA; Ruthenium; Ruthenium Compounds

2022